Skip to main content
Erschienen in: Breast Cancer 4/2020

30.01.2020 | Case Report

A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?

verfasst von: Takumi Gohara, Makoto Komura, Aya Asano, Takaki Emura, Kazuko Obana, Toru Kikuchi, Hironobu Yonekawa, Hiroaki Komuro, Tetsuro Kodaka, Kan Terawaki, Toshiaki Saeki, Akihiko Osaki, Chih-Ping Li, Keisuke Ishizawa, Takahiro Hasebe, Hitoshi Tsuda, Atsushi Sasaki

Erschienen in: Breast Cancer | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Secretory breast carcinoma constitutes the majority of breast cancers in children and young people less than 20 years of age. Noninvasive examination is particularly necessary for the diagnosis of breast carcinoma in children. Herein, we report a case of secretory breast carcinoma in a 6-year-old girl with psychomotor retardation. She was referred to our outpatient clinic for evaluation of a palpable mass in her left breast. A hard mass, rather than the increase in size typical of premature thelarche, was palpated. An excision biopsy was performed. Pathological findings revealed an invasive secretory breast carcinoma. We performed a retrospective review of the preoperative findings of this case, and compared it to the pathological diagnosis. Elastography, which can be performed without deep sedation or general anesthesia and without causing pain, resulted in a stiffness score of 4; however, the distinction between benign and malignant tumors on elastography, which is important to decide the intra-operative procedures, was not sufficient according to the Japanese breast cancer society clinical guidelines. This is the first report of secretory breast carcinoma in a child with a stiffness score determined by tissue elasticity imaging. A breast mass in a child with a high stiffness score of more than 4 on elastography should be referred for invasive diagnostic procedures, such as fine needle aspiration or excisional biopsy. According to our experience, an accurate preoperative diagnosis could be possible for malignant breast tumors in children. Such parameters as stiffness score on elastography are practical, noninvasive, and objective diagnostic tools for the accurate preoperative diagnosis of breast tumors in children.
Literatur
1.
Zurück zum Zitat Lee SG, Jung SP, Lee HY, Kim S, Kim HY, Kim I, et al. Secretory breast carcinoma: a report of three cases and a review of the literature. Oncol Lett. 2014;8:683–6.CrossRef Lee SG, Jung SP, Lee HY, Kim S, Kim HY, Kim I, et al. Secretory breast carcinoma: a report of three cases and a review of the literature. Oncol Lett. 2014;8:683–6.CrossRef
2.
Zurück zum Zitat Doğan G, Soyer T, Ekinci S, Karnak İ, Çiftçi AÖ, Tanyel FC. Evaluation of surgically treated breast masses in children. Turk J Pediatr. 2017;59:177–83.CrossRef Doğan G, Soyer T, Ekinci S, Karnak İ, Çiftçi AÖ, Tanyel FC. Evaluation of surgically treated breast masses in children. Turk J Pediatr. 2017;59:177–83.CrossRef
3.
Zurück zum Zitat Richards MK, Goldin AB, Beierle EA, Doski JJ, Goldfarb M, Langer M, et al. Breast malignancies in children: presentation, management, and survival. Ann Surg Oncol. 2017;24:1482–91.CrossRef Richards MK, Goldin AB, Beierle EA, Doski JJ, Goldfarb M, Langer M, et al. Breast malignancies in children: presentation, management, and survival. Ann Surg Oncol. 2017;24:1482–91.CrossRef
4.
Zurück zum Zitat Murphy JJ, Morzaria S, Gow KW, Magee JF. Breast cancer in a 6-year-old child. J Pediatr Surg. 2000;35:765–7.CrossRef Murphy JJ, Morzaria S, Gow KW, Magee JF. Breast cancer in a 6-year-old child. J Pediatr Surg. 2000;35:765–7.CrossRef
5.
Zurück zum Zitat Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.CrossRef Itoh A, Ueno E, Tohno E, Kamma H, Takahashi H, Shiina T, et al. Breast disease: clinical application of US elastography for diagnosis. Radiology. 2006;239:341–50.CrossRef
6.
Zurück zum Zitat Kazi M, Parshad R, Seenu V, Mathur S, Haresh KP. Fine-needle aspiration cytology (FNAC) in breast cancer: a reappraisal based on retrospective review of 698 cases. World J Surg. 2017;41:1528–33.CrossRef Kazi M, Parshad R, Seenu V, Mathur S, Haresh KP. Fine-needle aspiration cytology (FNAC) in breast cancer: a reappraisal based on retrospective review of 698 cases. World J Surg. 2017;41:1528–33.CrossRef
7.
Zurück zum Zitat Buchino JJ, Moore GD, Bond SJ. Secretory carcinoma in a 9-year-old girl. Diagn Cytopathol. 2004;31:430–1.CrossRef Buchino JJ, Moore GD, Bond SJ. Secretory carcinoma in a 9-year-old girl. Diagn Cytopathol. 2004;31:430–1.CrossRef
8.
Zurück zum Zitat Misra M, Sagar P, Friedmann AM, Ryan DP, Sgroi DC. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-year-old boy with an enlarging mass in the right breast. N Engl J Med. 2016;374:1565–74.CrossRef Misra M, Sagar P, Friedmann AM, Ryan DP, Sgroi DC. CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 12-2016. An 8-year-old boy with an enlarging mass in the right breast. N Engl J Med. 2016;374:1565–74.CrossRef
9.
Zurück zum Zitat Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med. 2011;135:1606–10.CrossRef Vasudev P, Onuma K. Secretory breast carcinoma: unique, triple-negative carcinoma with a favorable prognosis and characteristic molecular expression. Arch Pathol Lab Med. 2011;135:1606–10.CrossRef
10.
Zurück zum Zitat Richard G, Hawk JC 3rd, Baker AS Jr, Austin RM. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature. J Surg Oncol. 1990;44:238–44.CrossRef Richard G, Hawk JC 3rd, Baker AS Jr, Austin RM. Multicentric adult secretory breast carcinoma: DNA flow cytometric findings, prognostic features, and review of the world literature. J Surg Oncol. 1990;44:238–44.CrossRef
11.
Zurück zum Zitat Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 1989;14:25–36.CrossRef Krausz T, Jenkins D, Grontoft O, Pollock DJ, Azzopardi JG. Secretory carcinoma of the breast in adults: emphasis on late recurrence and metastasis. Histopathology. 1989;14:25–36.CrossRef
12.
Zurück zum Zitat Vieni S, Cabibi D, Cipolla C, Fricano S, Graceffa G, Latteri MA. Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol. 2006;4:88.CrossRef Vieni S, Cabibi D, Cipolla C, Fricano S, Graceffa G, Latteri MA. Secretory breast carcinoma with metastatic sentinel lymph node. World J Surg Oncol. 2006;4:88.CrossRef
13.
Zurück zum Zitat de Bree E, Askoxylakis J, Giannikaki E, Chroniaris N, Sanidas E, Tsiftsis DD. Secretory carcinoma of the male breast. Ann Surg Oncol. 2002;9:663–7.CrossRef de Bree E, Askoxylakis J, Giannikaki E, Chroniaris N, Sanidas E, Tsiftsis DD. Secretory carcinoma of the male breast. Ann Surg Oncol. 2002;9:663–7.CrossRef
Metadaten
Titel
A case of secretory breast cancer in a 6 year-old girl: is it possible to make a correct preoperative diagnosis?
verfasst von
Takumi Gohara
Makoto Komura
Aya Asano
Takaki Emura
Kazuko Obana
Toru Kikuchi
Hironobu Yonekawa
Hiroaki Komuro
Tetsuro Kodaka
Kan Terawaki
Toshiaki Saeki
Akihiko Osaki
Chih-Ping Li
Keisuke Ishizawa
Takahiro Hasebe
Hitoshi Tsuda
Atsushi Sasaki
Publikationsdatum
30.01.2020
Verlag
Springer Japan
Erschienen in
Breast Cancer / Ausgabe 4/2020
Print ISSN: 1340-6868
Elektronische ISSN: 1880-4233
DOI
https://doi.org/10.1007/s12282-020-01056-5

Weitere Artikel der Ausgabe 4/2020

Breast Cancer 4/2020 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.